Literature DB >> 2572109

An epidemiological study of rosacea.

M Berg1, S Lidén.   

Abstract

In a non-selected population of 809 office employees (454 women and 355 men) 81 persons were diagnosed as having rosacea, giving a prevalence of 10% (women 14%, men 5%). The rosacea group was compared with the rest of the study population. Most of the cases were rather mild. The rosacea was of an erythematotelangiectatic type in 81% of the cases and of a papulopustular type in 19%. Unilateral lesions were found in 11 subjects (14%). Only 17% of those with rosacea were impaired by sunlight, whereas 26% improved. In the rosacea group, 27% were found to suffer from migraine and 42% from a tendency to flush, compared with 13% (p less than 0.001) and 16% (p less than 0.001) respectively in the comparison group. Flushing and the regulatory mechanism of the blood vessels thus seem to be of importance in the pathogenesis of rosacea. Individuals with good pigmentation ability showed a tendency to a decreased occurrence of rosacea. The frequency of eye complaints was the same in the two groups.

Entities:  

Mesh:

Year:  1989        PMID: 2572109

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  32 in total

Review 1.  [Rosacea 2009 : new advances in pathophysiology, clinical staging and therapeutic strategies].

Authors:  A Sobottka; P Lehmann
Journal:  Hautarzt       Date:  2009-12       Impact factor: 0.751

2.  Rosacea: a review.

Authors:  Brittney Culp; Noah Scheinfeld
Journal:  P T       Date:  2009-01

Review 3.  Rosacea: classification and treatment.

Authors:  T Jansen; G Plewig
Journal:  J R Soc Med       Date:  1997-03       Impact factor: 5.344

4.  Clinical evaluation of 168 korean patients with rosacea: the sun exposure correlates with the erythematotelangiectatic subtype.

Authors:  You In Bae; Sook-Jung Yun; Jee-Bum Lee; Seong-Jin Kim; Young Ho Won; Seung-Chul Lee
Journal:  Ann Dermatol       Date:  2009-08-31       Impact factor: 1.444

5.  Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies.

Authors:  J Fowler; M Jarratt; A Moore; K Meadows; A Pollack; M Steinhoff; Y Liu; M Leoni
Journal:  Br J Dermatol       Date:  2012-03       Impact factor: 9.302

6.  Expression of vascular endothelial growth factor and its receptors in rosacea.

Authors:  Justine R Smith; Virginia B Lanier; Rita M Braziel; Katherine M Falkenhagen; Clifton White; James T Rosenbaum
Journal:  Br J Ophthalmol       Date:  2007-02       Impact factor: 4.638

Review 7.  [Rosacea. Clinical features, pathogenesis and therapy].

Authors:  P Lehmann
Journal:  Hautarzt       Date:  2005-09       Impact factor: 0.751

8.  Overgrowth of oral mucosa and facial skin, a novel feature of aspartylglucosaminuria.

Authors:  P Arvio; M Arvio; M Kero; S Pirinen; P L Lukinmaa
Journal:  J Med Genet       Date:  1999-05       Impact factor: 6.318

Review 9.  Interventions for rosacea.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Ben Carter; Mireille M D van der Linden; Lyn Charland
Journal:  Cochrane Database Syst Rev       Date:  2015-04-28

Review 10.  Cutaneous lesions of the nose.

Authors:  Michael Sand; Daniel Sand; Christina Thrandorf; Volker Paech; Peter Altmeyer; Falk G Bechara
Journal:  Head Face Med       Date:  2010-06-04       Impact factor: 2.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.